- Home
- ITGR vs KRYS Comparison
ITGR vs KRYS Comparison
Compare ITGR & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITGR
- KRYS
- Stock Information
- Founded
- ITGR 1970
- KRYS 2015
- Country
- ITGR United States
- KRYS United States
- Employees
- ITGR N/A
- KRYS N/A
- Industry
- ITGR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ITGR Health Care
- KRYS Health Care
- Exchange
- ITGR Nasdaq
- KRYS Nasdaq
- Market Cap
- ITGR 4.2B
- KRYS 4.3B
- IPO Year
- ITGR 2000
- KRYS 2017
- Fundamental
- Price
- ITGR $103.54
- KRYS $155.88
- Analyst Decision
- ITGR Strong Buy
- KRYS Strong Buy
- Analyst Count
- ITGR 9
- KRYS 9
- Target Price
- ITGR $141.78
- KRYS $203.22
- AVG Volume (30 Days)
- ITGR 325.8K
- KRYS 291.1K
- Earning Date
- ITGR 10-23-2025
- KRYS 11-03-2025
- Dividend Yield
- ITGR N/A
- KRYS N/A
- EPS Growth
- ITGR N/A
- KRYS 36.22
- EPS
- ITGR 2.31
- KRYS 4.91
- Revenue
- ITGR $1,794,800,000.00
- KRYS $359,205,000.00
- Revenue This Year
- ITGR $10.92
- KRYS $34.33
- Revenue Next Year
- ITGR $7.35
- KRYS $47.84
- P/E Ratio
- ITGR $44.44
- KRYS $31.49
- Revenue Growth
- ITGR 9.64
- KRYS 116.08
- 52 Week Low
- ITGR $99.73
- KRYS $122.80
- 52 Week High
- ITGR $146.36
- KRYS $207.84
- Technical
- Relative Strength Index (RSI)
- ITGR 43.01
- KRYS 52.93
- Support Level
- ITGR $99.73
- KRYS N/A
- Resistance Level
- ITGR $108.43
- KRYS $156.25
- Average True Range (ATR)
- ITGR 2.30
- KRYS 4.83
- MACD
- ITGR -0.22
- KRYS -4.72
- Stochastic Oscillator
- ITGR 42.39
- KRYS 99.84
About ITGR Integer Holdings Corporation
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.